Trial
NCT03407482
An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Genentech, Inc.
Collaborators
—
Condition
Lupus Erythematosus, Systemic
Intervention
GDC-0853
Why stopped
The study was ended early due to the lack of efficacy seen in the parent study GA30044.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-12-19